Overview
Yusuke Takanashi practices in Hamamatsu, Japan. Mr. Takanashi is rated as an Experienced expert by MediFind in the treatment of Collapsed Lung. His top areas of expertise are Squamous Cell Lung Carcinoma, Pulmonary Sequestration, Lung Adenocarcinoma, Retropharyngeal Abscess, and Endoscopy.
His clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Collapsed Lung.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Squamous Cell Lung CarcinomaMr. Takanashi isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Lung AdenocarcinomaMr. Takanashi isAdvanced. Learn about Lung Adenocarcinoma.
- Pulmonary SequestrationMr. Takanashi isAdvanced. Learn about Pulmonary Sequestration.
- Retropharyngeal AbscessMr. Takanashi isAdvanced. Learn about Retropharyngeal Abscess.
- Experienced
- Adenoid Cystic CarcinomaMr. Takanashi isExperienced. Learn about Adenoid Cystic Carcinoma.
- BullaeMr. Takanashi isExperienced. Learn about Bullae.
- Collapsed LungMr. Takanashi isExperienced. Learn about Collapsed Lung.
- EndoscopyMr. Takanashi isExperienced. Learn about Endoscopy.
- HerniaMr. Takanashi isExperienced. Learn about Hernia.
- Laryngeal CancerMr. Takanashi isExperienced. Learn about Laryngeal Cancer.